(PharmaNewsWire.Com, February 27, 2017 ) According to the report Europe Tumor Ablation, published by Market Data Forecast, the European Market was worth $86.25 billion in 2016 and estimated to be growing at a CAGR of 11.6%, to reach $149.31 million by 2021.
Tumors are the group of abnormal cells that accumulate together and form lumps. Tumor ablation is a minimally invasive procedure used to destroy cancer cells in the chest, lung and liver.Rising Prevalence of cancer is proportional to the growth of growth of tumor ablation market. According to the recent statistics published by the WHO, cancer accounts for 13% of the deaths worldwide. Cancer incidence is expected to increase by 70% over the next couple of decades.
Europe Tumor Ablation Market is driven by key factors such as growing geriatric population across the continent, increasing number of people affected with cancer; technological advancements in the field of ablation. Increasing demand for minimally invasive cancer treatment procedures and rising awareness regarding the benefits offered by ablation procedures over the conventional surgical procedures are also some of the factors boosting the growth of the market. However challenges related to ablation procedures and stringent regulatory guidelines and high costs are some of the factors restraining the market growth.
Europe tumor ablation market is segmented by technology, treatment and application. By technology the market is further sub-segmented into Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices. Radiofrequency devices is the dominating technology segment accounting for a share of about 35% attributed to its crucial role in solid tumour removal in the body. Based on treatment the market is segmented as Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation. Surgical Procedures segment accounted for a prominent share of around 37% owing to increasing prevalence of liver and breast cancers. Based on application Europe Tumor Ablation Market is segmented as Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer.
Tumor Ablation Market is segmented as follows: By Technology Radiofrequency Ablation Devices, Microwave Ablation Devices, Cryoablation Devices and other Ablation Devices By Treatment Surgical Ablation, Laparoscopic Ablation and Percutaneous Ablation By Application Liver Cancer, Breast Cancer, Lung Cancer, Prostrate Metastasis and other cancer
Based on Geography
Some of the key companies dominating the market include Medtronic Plc., Boston Scientific Corporation, Angiodynamics, Mermaid Medical, HealthTronics, Galil Medical Inc., EDAP TMS S.A., SonaCare Medical, Misonix, Inc. and Neuwave Medical, Inc.
The Tumor Ablation Market study offers the following deliverables: Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped. Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
Checkout related reports in the Medical Devices Market Category:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
